LYRA THERAPEUTICS INC (LYRA) Stock Analyst Ratings
NASDAQ:LYRA - Nasdaq - US55234L1052 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 49% to LYRA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.27. This target is 493.85% above the current price.
LYRA was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about LYRA.
In the last month the buy percentage fell by 26 points. So the trust of analysts is decreasing.
LYRA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-08-15 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-06-20 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-05-07 | Jefferies | Downgrade | Buy -> Hold |
| 2024-05-07 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-05-06 | BTIG | Downgrade | Buy -> Neutral |
| 2024-05-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-25 | B of A Securities | Maintains | Buy -> Buy |
| 2024-03-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-12 | B of A Securities | Maintains | Buy -> Buy |
| 2023-08-31 | HC Wainwright & Co. | Initiate | Buy |
| 2023-02-07 | BTIG | Maintains | Buy |
| 2022-05-24 | Cantor Fitzgerald | Initiate | Overweight |